Aerpio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases, announced that President and CEO Joseph Gardner, PhD, will present at the 13th Annual Needham Healthcare Conference on Wednesday, April 9, 2014, at 9:20 am ET. Dr. Gardner will highlight the Company’s lead compound, AKB-9778, a Tie2 activator for the treatment of diabetic macular edema (DME).
Help employers find you! Check out all the jobs and post your resume.
